Literature DB >> 23926200

Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.

Margaret L Hoang1, Chung-Hsin Chen, Viktoriya S Sidorenko, Jian He, Kathleen G Dickman, Byeong Hwa Yun, Masaaki Moriya, Noushin Niknafs, Christopher Douville, Rachel Karchin, Robert J Turesky, Yeong-Shiau Pu, Bert Vogelstein, Nickolas Papadopoulos, Arthur P Grollman, Kenneth W Kinzler, Thomas A Rosenquist.   

Abstract

In humans, exposure to aristolochic acid (AA) is associated with urothelial carcinoma of the upper urinary tract (UTUC). Exome sequencing of UTUCs from 19 individuals with documented exposure to AA revealed a remarkably large number of somatic mutations and an unusual mutational signature attributable to AA. Most of the mutations (72%) in these tumors were A:T-to-T:A transversions, located predominantly on the nontranscribed strand, with a strong preference for deoxyadenosine in a consensus sequence (T/CAG). This trinucleotide motif overlaps the canonical splice acceptor site, possibly accounting for the excess of splice site mutations observed in these tumors. The AA mutational fingerprint was found frequently in oncogenes and tumor suppressor genes in AA-associated UTUC. The AA mutational signature was observed in one patient's tumor from a UTUC cohort without previous indication of AA exposure. Together, these results directly link an established environmental mutagen to cancer through genome-wide sequencing and highlight its power to reveal individual exposure to carcinogens.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23926200      PMCID: PMC3973132          DOI: 10.1126/scitranslmed.3006200

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  52 in total

1.  TP53 Mutational signature for aristolochic acid: an environmental carcinogen.

Authors:  Masaaki Moriya; Neda Slade; Branko Brdar; Zvonimir Medverec; Karla Tomic; Bojan Jelaković; Lin Wu; Sim Truong; Andrea Fernandes; Arthur P Grollman
Journal:  Int J Cancer       Date:  2011-06-09       Impact factor: 7.396

2.  Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy.

Authors:  Marc E De Broe
Journal:  Kidney Int       Date:  2012-03       Impact factor: 10.612

3.  Endemic nephropathy: the case for chronic poisoning by aristolochia.

Authors:  Tjasa Hranjec; Anamarija Kovac; Jelena Kos; Wenyang Mao; John J Chen; Arthur P Grollman; Bojan Jelaković
Journal:  Croat Med J       Date:  2005-02       Impact factor: 1.351

4.  Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.

Authors:  Sergey I Nikolaev; Donata Rimoldi; Christian Iseli; Armand Valsesia; Daniel Robyr; Corinne Gehrig; Keith Harshman; Michel Guipponi; Olesya Bukach; Vincent Zoete; Olivier Michielin; Katja Muehlethaler; Daniel Speiser; Jacques S Beckmann; Ioannis Xenarios; Thanos D Halazonetis; C Victor Jongeneel; Brian J Stevenson; Stylianos E Antonarakis
Journal:  Nat Genet       Date:  2011-12-25       Impact factor: 38.330

5.  Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography/ion-trap mass spectrometry.

Authors:  Byeong Hwa Yun; Thomas A Rosenquist; Viktoriya Sidorenko; Charles R Iden; Chung-Hsin Chen; Yeong-Shiau Pu; Radha Bonala; Francis Johnson; Kathleen G Dickman; Arthur P Grollman; Robert J Turesky
Journal:  Chem Res Toxicol       Date:  2012-05-04       Impact factor: 3.739

6.  Aristolochic acid-associated urothelial cancer in Taiwan.

Authors:  Chung-Hsin Chen; Kathleen G Dickman; Masaaki Moriya; Jiri Zavadil; Viktoriya S Sidorenko; Karen L Edwards; Dmitri V Gnatenko; Lin Wu; Robert J Turesky; Xue-Ru Wu; Yeong-Shiau Pu; Arthur P Grollman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

7.  Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients.

Authors:  Donghai Xiong; Guangming Li; Kezhen Li; Qinzi Xu; Zhongjie Pan; Feng Ding; Peter Vedell; Pengyuan Liu; Peng Cui; Xing Hua; Hui Jiang; Yuxin Yin; Ze Zhu; Xiaomian Li; Bin Zhang; Ding Ma; Yian Wang; Ming You
Journal:  Carcinogenesis       Date:  2012-06-13       Impact factor: 4.944

8.  A comprehensive catalogue of somatic mutations from a human cancer genome.

Authors:  Erin D Pleasance; R Keira Cheetham; Philip J Stephens; David J McBride; Sean J Humphray; Chris D Greenman; Ignacio Varela; Meng-Lay Lin; Gonzalo R Ordóñez; Graham R Bignell; Kai Ye; Julie Alipaz; Markus J Bauer; David Beare; Adam Butler; Richard J Carter; Lina Chen; Anthony J Cox; Sarah Edkins; Paula I Kokko-Gonzales; Niall A Gormley; Russell J Grocock; Christian D Haudenschild; Matthew M Hims; Terena James; Mingming Jia; Zoya Kingsbury; Catherine Leroy; John Marshall; Andrew Menzies; Laura J Mudie; Zemin Ning; Tom Royce; Ole B Schulz-Trieglaff; Anastassia Spiridou; Lucy A Stebbings; Lukasz Szajkowski; Jon Teague; David Williamson; Lynda Chin; Mark T Ross; Peter J Campbell; David R Bentley; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2009-12-16       Impact factor: 49.962

9.  FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.

Authors:  Johanna M M van Oers; Ellen C Zwarthoff; Ishtiaq Rehman; Abdel-Rahmene Azzouzi; Olivier Cussenot; Mark Meuth; Freddie C Hamdy; James W F Catto
Journal:  Eur Urol       Date:  2008-06-13       Impact factor: 20.096

10.  Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

Authors:  Marcin Imielinski; Alice H Berger; Peter S Hammerman; Bryan Hernandez; Trevor J Pugh; Eran Hodis; Jeonghee Cho; James Suh; Marzia Capelletti; Andrey Sivachenko; Carrie Sougnez; Daniel Auclair; Michael S Lawrence; Petar Stojanov; Kristian Cibulskis; Kyusam Choi; Luc de Waal; Tanaz Sharifnia; Angela Brooks; Heidi Greulich; Shantanu Banerji; Thomas Zander; Danila Seidel; Frauke Leenders; Sascha Ansén; Corinna Ludwig; Walburga Engel-Riedel; Erich Stoelben; Jürgen Wolf; Chandra Goparju; Kristin Thompson; Wendy Winckler; David Kwiatkowski; Bruce E Johnson; Pasi A Jänne; Vincent A Miller; William Pao; William D Travis; Harvey I Pass; Stacey B Gabriel; Eric S Lander; Roman K Thomas; Levi A Garraway; Gad Getz; Matthew Meyerson
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

View more
  107 in total

1.  Bladder cancer: aristolochic acid--one of the most potent carcinogens known to man.

Authors:  Melanie Clyne
Journal:  Nat Rev Urol       Date:  2013-08-27       Impact factor: 14.432

Review 2.  Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.

Authors:  Renumathy Dhanasekaran; Jean-Charles Nault; Lewis R Roberts; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2018-11-04       Impact factor: 22.682

Review 3.  DNA adducts: Formation, biological effects, and new biospecimens for mass spectrometric measurements in humans.

Authors:  Byeong Hwa Yun; Jingshu Guo; Medjda Bellamri; Robert J Turesky
Journal:  Mass Spectrom Rev       Date:  2018-06-11       Impact factor: 10.946

Review 4.  Somatic mutation load and spectra: A record of DNA damage and repair in healthy human cells.

Authors:  Natalie Saini; Dmitry A Gordenin
Journal:  Environ Mol Mutagen       Date:  2018-08-27       Impact factor: 3.216

Review 5.  Hypermutation in human cancer genomes: footprints and mechanisms.

Authors:  Steven A Roberts; Dmitry A Gordenin
Journal:  Nat Rev Cancer       Date:  2014-12       Impact factor: 60.716

6.  Y-family DNA polymerase-independent gap-filling translesion synthesis across aristolochic acid-derived adenine adducts in mouse cells.

Authors:  Keiji Hashimoto; Radha Bonala; Francis Johnson; Arthur P Grollman; Masaaki Moriya
Journal:  DNA Repair (Amst)       Date:  2016-07-29

7.  Update on The Cancer Genome Atlas Project on Muscle-invasive Bladder Cancer.

Authors:  Seth P Lerner
Journal:  Eur Urol Focus       Date:  2015-08

8.  Low-Coverage Exome Sequencing Screen in Formalin-Fixed Paraffin-Embedded Tumors Reveals Evidence of Exposure to Carcinogenic Aristolochic Acid.

Authors:  Xavier Castells; Sandra Karanović; Maude Ardin; Karla Tomić; Evanguelos Xylinas; Geoffroy Durand; Stephanie Villar; Nathalie Forey; Florence Le Calvez-Kelm; Catherine Voegele; Krešimir Karlović; Maja Mišić; Damir Dittrich; Igor Dolgalev; James McKay; Shahrokh F Shariat; Viktoria S Sidorenko; Andrea Fernandes; Adriana Heguy; Kathleen G Dickman; Magali Olivier; Arthur P Grollman; Bojan Jelaković; Jiri Zavadil
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-17       Impact factor: 4.254

9.  Chinese nonmedicinal herbal diet and risk of nasopharyngeal carcinoma: A population-based case-control study.

Authors:  Chuyang Lin; Su-Mei Cao; Ellen T Chang; Zhiwei Liu; Yonglin Cai; Zhe Zhang; Guomin Chen; Qi-Hong Huang; Shang-Hang Xie; Yu Zhang; Jingping Yun; Wei-Hua Jia; Yuming Zheng; Jian Liao; Yufeng Chen; Longde Lin; Qing Liu; Ingemar Ernberg; Guangwu Huang; Yi Zeng; Yi-Xin Zeng; Hans-Olov Adami; Weimin Ye
Journal:  Cancer       Date:  2019-09-22       Impact factor: 6.860

Review 10.  Safety surveillance of traditional Chinese medicine: current and future.

Authors:  Shwu-Huey Liu; Wu-Chang Chuang; Wing Lam; Zaoli Jiang; Yung-Chi Cheng
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.